Amneal Pharmaceuticalsincis A Global Biopharmaceutical Company Based In Bridgewaternew Jerseyfounded In 2002The Company Operates In Three Main Segmentsaffordable Medicinesspecialty Pharmaceuticalsand Avkareamneal Is Dedicated To Making Healthcare Accessible Through A Wide Range Of Generic And Specialty Pharmaceuticalsoffering Over 280 Products Primarily In The U Smarket The Affordable Medicines Segment Includes Generic Injectablesbiosimilarsand Retail Genericscatering To Cost Sensitive Marketsspecialty Pharmaceuticals Focuses On Treatments For Central Nervous System And Endocrine Disorderswith Branded Drugs For Conditions Like Parkinsonae S Diseasethe Avkare Segment Supplies Pharmaceuticals To U Sfederal Agenciesretail Pharmaciesand Institutional Buyersincluding Military Healthcare Programsamneal Has A Strong Emphasis On Complex Genericsbiosimilarsand Branded Therapiessupported By Advanced Manufacturing Capabilities And A Global Commercial Infrastructurethe Company Has Grown Through Strategic Mergersincluding Its Combination With Impax Laboratoriesand Continues To Invest In Research And Development To Enhance Its Product Offerings And Expand Its Market Reach
